Dhingra, S. and Sachdeva, M. 2017. Expanding horizons in the treatment of mantle cell lymphoma: Ibrutinib a novel BTK-targeting inhibitor. International Journal of Basic & Clinical Pharmacology. 3, 1 (Jan. 2017), 249–254.